Update on Comprehensive Test Ban, & More from CRS
The Congressional Research Service has prepared an updated account of the status of the comprehensive nuclear test ban treaty (CTBT), which would prohibit explosive testing of nuclear weapons.
“As of August 2016, 183 states had signed the CTBT and 164, including Russia, had ratified it. However, entry into force requires ratification by 44 states specified in the treaty, of which 41 had signed the treaty and 36 had ratified.” The U.S. has not ratified it.
The Senate Foreign Relations Committee will hold a hearing on the CTBT tomorrow, September 7.
See Comprehensive Nuclear-Test-Ban Treaty: Background and Current Developments, September 1, 2016.
Other new and updated products from the Congressional Research Service include the following.
Climate Change: Frequently Asked Questions about the 2015 Paris Agreement, September 1, 2016
U.S. Textile Manufacturing and the Proposed Trans-Pacific Partnership Agreement, September 1, 2016
Comparing DHS Component Funding, FY2017: Fact Sheet, September 2, 2016
OPM Announces Premium Increase in the Federal Long-Term Care Insurance Program, CRS Insight, September 1, 2016
The European Union’s Small Business Act: A Different Approach, September 1, 2016
Zika Response Funding: Request and Congressional Action, updated September 1, 2016
No one will be surprised if we end up with a continuing resolution to push our shutdown deadline out past the midterms, so the real question is what else will they get done this summer?
Rebuilding public participation starts with something simple — treating the public not as a problem to manage, but as a source of ingenuity government cannot function without.
If the government wants a system of learning and adaptation that improves results in real time, it has to treat translation, utilization, and adaptation as core functions of governance rather than as afterthoughts.
Coordination among federal science agencies is essential to ensure government-wide alignment on R&D investment priorities. However, the federal R&D enterprise suffers from egregious siloization.